Effect of advanced access scheduling on chronic health care in a Canadian practice.
OBJECTIVE
To determine the effect of advanced access scheduling (AAS) on the care of patients with chronic disease within a Canadian family practice.


METHODS
Chart abstraction.


METHODS
A single family physician's practice in Brantford, Ont.


METHODS
Patient charts were reviewed for all patients with a history of hypertension, type 2 diabetes mellitus, or coronary artery disease during the years before and after implementation of AAS.


METHODS
The following information was extracted for each study patient: total number of appointments, number of appointments specific to chronic disease management, number of appointments for non-chronic disease, blood pressure (BP), and laboratory markers, including hemoglobin A(1c) (HbA(1c)) and low-density lipoprotein levels.


RESULTS
For the year before and the year after implementation of AAS, the mean number of visits per patient was 4.3. The mean number of appointments for chronic disease management decreased significantly from 2.6 to 2.2 (P = .024), and the mean number of visits for non-chronic disease increased significantly from 1.7 to 2.1 (P = .001). The number of times clinical parameters of BP, HbA(1c), and low-density lipoprotein were measured decreased; however, there were no significant changes in actual BP or HbA(1c) levels.


CONCLUSIONS
Following a 1-year period using AAS, use of the family health practice by patients with chronic disease was unchanged overall; however, AAS allowed for an increase in visits for non-chronic health conditions without significantly affecting the clinical parameters of BP or HbA(1c).
julie.gladstone@medportal.ca
Julie
J
Gladstone
Michelle
M
Howard
D000368:Aged; D001071:Appointments and Schedules; D001794:Blood Pressure / Q000502:physiology; D008078:Cholesterol, LDL / Q000032:analysis / Q000097:blood; D002908:Chronic Disease / Q000517:prevention & control* / Q000628:therapy; D003324:Coronary Artery Disease / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D019468:Disease Management; D005194:Family Practice / Q000379:methods* / Q000592:standards; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006297:Health Services Accessibility / Q000458:organization & administration; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D008297:Male; D008499:Medical Records; D009819:Office Visits / Q000706:statistics & numerical data* / Q000639:trends; D009864:Ontario; D013997:Time Factors
D008078:Cholesterol, LDL; D006442:Glycated Hemoglobin
J Gen Intern Med. 2009 Mar;24(3):327-33
19132326
CMAJ. 2009 Jul 7;181(1-2):37-44
19581618
Am J Manag Care. 2004 Oct;10(10):717-22
15521163
Prev Chronic Dis. 2008 Jan;5(1):A16
18082005
JAMA. 2003 Feb 26;289(8):1035-40
12597760
Can Fam Physician. 2008 Mar;54(3):379-83
18337532
JAMA. 2003 Feb 26;289(8):1042-6
12597761
Fam Pract Manag. 2006 Mar;13(3):59-64
16568598
Fam Pract Manag. 2004 Feb;11(2):35-8
15011480